All sites C00-96,D32-33,D42-43,D45-47,D76 594 88.9 2.9 3.9 0.9 3.4
Mouth, pharynx C00-14 12 98.3 - - - 1.7
  Lip C00 2 100.0 - - - -
  Tongue C02 4 100.0 - - - -
  Mouth, other C03-06 2 100.0 - - - -
  Salivary glands C07-08 2 90.9 - - - 9.1
  Pharynx C01,C09-14 2 100.0 - - - -
Digestive organs C15-26 109 79.6 2.4 10.9 2.0 5.2
  Oesophagus C15 4 95.0 - - 5.0 -
  Stomach C16 11 96.3 - 3.7 - -
  Small intestine C17 1 75.0 - 25.0 - -
  Colon C18 35 97.1 - 1.1 0.6 1.1
  Rectum, rectosigmoid C19-20 19 95.8 - 1.1 - 3.2
  Anus C21 1 100.0 - - - -
  Liver C22 8 51.2 - 41.5 2.4 4.9
  Gallbladder, bile ducts C23-24 7 54.1 8.1 13.5 2.7 21.6
  Pancreas C25 20 50.0 10.0 26.0 4.0 10.0
  Other digestive organs C26 3 26.7 - 33.3 20.0 20.0
Respiratory organs C30-39 22 75.7 9.9 8.1 1.8 4.5
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 1 100.0 - - - -
  Lung, trachea C33-34 20 75.5 10.8 6.9 2.0 4.9
  Mediastinum, pleura C38 0 - - 100.0 - -
Bone C40-41 1 100.0 - - - -
Melanoma of the skin C43 21 100.0 - - - -
Skin, non-melanoma C44 42 99.5 - - - 0.5
Mesothelioma C45 1 100.0 - - - -
Autonomic nervous system C47 0 100.0 - - - -
Soft tissues C48-49 3 93.8 - - - 6.3
Breast C50 183 99.3 0.2 0.1 0.2 0.1
Female genital organs C51-58 73 94.8 1.7 1.7 0.3 1.7
  Cervix uteri C53 6 96.4 - - 3.6 -
  Corpus uteri C54 40 99.5 - 0.5 - -
  Uterus, other C55,C58 0 100.0 - - - -
  Ovary C56 18 84.6 6.6 4.4 - 4.4
  Other female genital C51-52,C57 8 92.7 - 2.4 - 4.9
Urinary organs C64-68 25 87.3 - 4.0 0.8 7.9
  Kidney C64 16 82.1 - 6.4 - 11.5
  Bladder and urinary tract2 C65-68 10 95.8 - - 2.1 2.1
Eye C69 0 - - 50.0 50.0 -
Brain, central nervous system C70-72,D32-33,D42-43 18 81.3 - 6.6 - 12.1
Thyroid gland C73 11 100.0 - - - -
Other endocrine glands C74-75 0 100.0 - - - -
Illdefined or unknown C76,C80 17 50.6 8.0 19.5 6.9 14.9
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 55 69.1 16.7 4.0 1.5 8.7
  Hodgkin lymphoma C81 2 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 22 99.1 - - - 0.9
  Malignant immunoproliferative diseases C88 1 80.0 - - - 20.0
  Myeloma and other plasma cell tumors C90 7 34.3 11.4 28.6 5.7 20.0
  Leukaemia C91-95 12 61.0 28.8 - 1.7 8.5
  Myelodysplastic syndromes D46 4 11.1 44.4 5.6 5.6 33.3
  Myeloproliferaitive neoplasms D45,D47 8 44.7 44.7 - - 10.5
Not included above
  Carcinoma in situ of the breast D05 9 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 37 100.0 - - - -
  Borderline tumour of the ovary D39 4 100.0 - - - -
  Basal cell carcinoma of the skin 66 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.